Oliver Luxxe Assets LLC Regeneron Pharmaceuticals, Inc. Transaction History

Oliver Luxxe Assets LLC

  • $528 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $4.37 Million - $5.12 Million
-7,337 Closed
0 $0
Q4 2021

Feb 16, 2022
BUY
$543.48 - $670.97 $88,043 - $108,697
162 Added 2.26%
7,337 $4.63 Million
Q3 2021

Nov 10, 2021
BUY
$574.03 - $680.96 $4.12 Million - $4.89 Million
7,175 New
7,175 $4.34 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Oliver Luxxe Assets LLC Portfolio

Follow Oliver Luxxe Assets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Luxxe Assets LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email